{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:27:45Z","timestamp":1789518465843,"version":"build-2803163510"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["NO. 2025-NHLHCRF-JBGS-A-WZ-13"],"award-info":[{"award-number":["NO. 2025-NHLHCRF-JBGS-A-WZ-13"]}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 82374224"],"award-info":[{"award-number":["NO. 82374224"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["NO. 7252270"],"award-info":[{"award-number":["NO. 7252270"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08131-z","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:47:11Z","timestamp":1777481231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Carnitine dysregulation in diabetic kidney disease: from pathogenic mechanism to precision biomarker"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuanhua","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiru","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"8131_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2023.09.009","author":"H Hu","year":"2023","unstructured":"Hu H, Liang W, Ding G. Ion homeostasis in diabetic kidney disease. Trends Endocrinol Metabolism. 2023. https:\/\/doi.org\/10.1016\/j.tem.2023.09.009.","journal-title":"Trends Endocrinol Metabolism"},{"key":"8131_CR2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.81892","author":"H Wang","year":"2023","unstructured":"Wang H, et al. Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities. Int J Biol Sci. 2023. https:\/\/doi.org\/10.7150\/ijbs.81892.","journal-title":"Int J Biol Sci"},{"key":"8131_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12122083","author":"SY Chae","year":"2023","unstructured":"Chae SY, Kim Y, Park CW. Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia. Antioxidants. 2023. https:\/\/doi.org\/10.3390\/antiox12122083.","journal-title":"Antioxidants"},{"key":"8131_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05078-y","author":"Y Hou","year":"2024","unstructured":"Hou Y, et al. Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney. Cell Mol Life Sci. 2024. https:\/\/doi.org\/10.1007\/s00018-023-05078-y.","journal-title":"Cell Mol Life Sci"},{"key":"8131_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02669-5","author":"Y-T Wang","year":"2025","unstructured":"Wang Y-T, et al. Defective lipid droplet biogenesis exacerbates oleic acid-induced cellular homeostasis disruption and ferroptosis in mouse cardiac endothelial cells. Cell Death Discovery. 2025. https:\/\/doi.org\/10.1038\/s41420-025-02669-5.","journal-title":"Cell Death Discovery"},{"key":"8131_CR6","doi-asserted-by":"publisher","DOI":"10.2337\/db23-0811","author":"Y Xie","year":"2024","unstructured":"Xie Y, et al. CPT1A Protects Podocytes from Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo. Diabetes. 2024. https:\/\/doi.org\/10.2337\/db23-0811.","journal-title":"Diabetes"},{"key":"8131_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1549484","author":"W Yu","year":"2025","unstructured":"Yu W, et al. Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1549484.","journal-title":"Front Immunol"},{"key":"8131_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01365-8","author":"JX Zhang","year":"2024","unstructured":"Zhang JX, et al. Deficiency of thiosulfate sulfurtransferase mediates the dysfunction of renal tubular mitochondrial fatty acid oxidation in diabetic kidney disease. Cell Death Differ. 2024. https:\/\/doi.org\/10.1038\/s41418-024-01365-8.","journal-title":"Cell Death Differ"},{"key":"8131_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2018.02.009","author":"MM Adeva-Andany","year":"2019","unstructured":"Adeva-Andany MM, et al. Mitochondrial \u03b2-oxidation of saturated fatty acids in humans. Mitochondrion. 2019. https:\/\/doi.org\/10.1016\/j.mito.2018.02.009.","journal-title":"Mitochondrion"},{"key":"8131_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0000000000000906","author":"M Malaguarnera","year":"2023","unstructured":"Malaguarnera M, Catania VE, Malaguarnera M. Carnitine derivatives beyond fatigue: an update. Curr Opin Gastroenterol. 2023. https:\/\/doi.org\/10.1097\/mog.0000000000000906.","journal-title":"Curr Opin Gastroenterol"},{"key":"8131_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000028853","author":"HK Yu","year":"2022","unstructured":"Yu HK, et al. Anesthetic management of patients with carnitine deficiency or a defect of the fatty acid \u03b2-oxidation pathway: A narrative review. Medicine. 2022. https:\/\/doi.org\/10.1097\/md.0000000000028853.","journal-title":"Medicine"},{"key":"8131_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2025.101199","author":"H Babazade","year":"2025","unstructured":"Babazade H, et al. Carglumic acid as a treatment for persistent hyperammonemia in carnitine-acylcarnitine translocase deficiency: A case study. Mol Genet Metabolism Rep. 2025. https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101199.","journal-title":"Mol Genet Metabolism Rep"},{"key":"8131_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/121.7.1117","author":"DC Honeyfield","year":"2023","unstructured":"Honeyfield DC, Froseth JA. Evaluation of Energy Sources with and without Carnitine in Newborn Pig Heart and Liver. J Nutr. 2023. https:\/\/doi.org\/10.1093\/jn\/121.7.1117.","journal-title":"J Nutr"},{"key":"8131_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194978","author":"C Lindquist","year":"2018","unstructured":"Lindquist C, et al. A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis. PLoS ONE. 2018. https:\/\/doi.org\/10.1371\/journal.pone.0194978.","journal-title":"PLoS ONE"},{"key":"8131_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jas\/skaf298","author":"A Rankovic","year":"2025","unstructured":"Rankovic A, et al. Serum metabolomics reveals one-carbon metabolism differences between lean and obese cats not affected by L-carnitine or choline supplementation. J Anim Sci. 2025. https:\/\/doi.org\/10.1093\/jas\/skaf298.","journal-title":"J Anim Sci"},{"key":"8131_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1198175","author":"A Rankovic","year":"2023","unstructured":"Rankovic A, et al. Dietary choline, but not L-carnitine, increases circulating lipid and lipoprotein concentrations, without affecting body composition, energy expenditure or respiratory quotient in lean and obese male cats during weight maintenance. Front Veterinary Sci. 2023. https:\/\/doi.org\/10.3389\/fvets.2023.1198175.","journal-title":"Front Veterinary Sci"},{"key":"8131_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-016-1049-y","author":"W-H Chuang","year":"2016","unstructured":"Chuang W-H, et al. Altered plasma acylcarnitine and amino acid profiles in type 2 diabetic kidney disease. Metabolomics. 2016. https:\/\/doi.org\/10.1007\/s11306-016-1049-y.","journal-title":"Metabolomics"},{"key":"8131_CR18","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.s350233","author":"X Mu","year":"2022","unstructured":"Mu X, et al. Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy? Diabetes Metabolic Syndrome Obesity: Targets Therapy. 2022. https:\/\/doi.org\/10.2147\/dmso.s350233.","journal-title":"Diabetes Metabolic Syndrome Obesity: Targets Therapy"},{"key":"8131_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010173","author":"M Rousseau","year":"2019","unstructured":"Rousseau M, et al. Associations Between Dietary Protein Sources, Plasma BCAA and Short-Chain Acylcarnitine Levels in Adults. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11010173.","journal-title":"Nutrients"},{"key":"8131_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/09674845.2021.1894705","author":"S Abdelsattar","year":"2021","unstructured":"Abdelsattar S, et al. Targeted metabolomics as a tool for the diagnosis of kidney disease in Type II diabetes mellitus. Br J Biomed Sci. 2021. https:\/\/doi.org\/10.1080\/09674845.2021.1894705.","journal-title":"Br J Biomed Sci"},{"key":"8131_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91281-9","author":"Y Hu","year":"2025","unstructured":"Hu Y, et al. Predicting diabetic kidney disease with serum metabolomics and gut microbiota. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-91281-9.","journal-title":"Sci Rep"},{"key":"8131_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-011-0291-6","author":"FM van der Kloet","year":"2011","unstructured":"van der Kloet FM, et al. Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics. 2011. https:\/\/doi.org\/10.1007\/s11306-011-0291-6.","journal-title":"Metabolomics"},{"key":"8131_CR23","doi-asserted-by":"publisher","first-page":"343856","DOI":"10.1016\/j.aca.2025.343856","volume":"1351","author":"X Gao","year":"2025","unstructured":"Gao X, Liu C, Zhao X. Isomer-resolved characterization of acylcarnitines reveals alterations in type 2 diabetes. Anal Chim Acta. 2025;1351:343856. https:\/\/doi.org\/10.1016\/j.aca.2025.343856.","journal-title":"Anal Chim Acta"},{"issue":"11","key":"8131_CR24","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1016\/j.apsb.2021.05.013","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang Z, et al. Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging. Acta Pharm Sin B. 2021;11(11):3665\u201377. https:\/\/doi.org\/10.1016\/j.apsb.2021.05.013.","journal-title":"Acta Pharm Sin B"},{"key":"8131_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/36.1.115","author":"FP Bell","year":"2018","unstructured":"Bell FP, et al. Carnitine metabolism in Macaca arctoides: the effects of dietary change and fasting on serum triglycerides, unesterified carnitine, esterified (acyl) carnitine, and \u03b2-hydroxybutyrate. Am J Clin Nutr. 2018. https:\/\/doi.org\/10.1093\/ajcn\/36.1.115.","journal-title":"Am J Clin Nutr"},{"key":"8131_CR26","doi-asserted-by":"publisher","DOI":"10.1042\/bj1361075","author":"RA Cox","year":"1973","unstructured":"Cox RA, Hoppel CL. Biosynthesis of carnitine and 4-N-trimethylaminobutyrate from lysine. Biochem J. 1973. https:\/\/doi.org\/10.1042\/bj1361075.","journal-title":"Biochem J"},{"key":"8131_CR27","doi-asserted-by":"publisher","DOI":"10.1042\/bj1361083","author":"RA Cox","year":"1973","unstructured":"Cox RA, Hoppel CL. Biosynthesis of carnitine and 4-N-trimethylaminobutyrate from 6-N-trimethyl-lysine. Biochem J. 1973. https:\/\/doi.org\/10.1042\/bj1361083.","journal-title":"Biochem J"},{"key":"8131_CR28","doi-asserted-by":"publisher","DOI":"10.1042\/bj1420699","author":"RA Cox","year":"1974","unstructured":"Cox RA, Hoppel CL. Carnitine and trimethylaminobutyrate synthesis in rat tissues. Biochem J. 1974. https:\/\/doi.org\/10.1042\/bj1420699.","journal-title":"Biochem J"},{"key":"8131_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(84)90392-1","author":"W Thoma","year":"1984","unstructured":"Thoma W. L <>Henderson 1984 Effect of vitamin C deficiency on hydroxylation of trimethylaminobutyrate to carnitine in the guinea pig. Biochim et Biophys Acta (BBA) - Gen Subj https:\/\/doi.org\/10.1016\/0304-4165(84)90392-1.","journal-title":"Biochim et Biophys Acta (BBA) - Gen Subj"},{"key":"8131_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-004-1590-y","author":"V Tsagris","year":"2005","unstructured":"Tsagris V, Liapi-Adamidou G. Serum carnitine levels in patients with homozygous beta thalassemia: a possible new role for carnitine? Eur J Pediatrics. 2005. https:\/\/doi.org\/10.1007\/s00431-004-1590-y.","journal-title":"Eur J Pediatrics"},{"key":"8131_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-08390-1_8","author":"HR Scholte","year":"1987","unstructured":"Scholte HR, Luyt-Houwen IEM, Vaandrager-Verduin MHM. The role of the carnitine system in myocardial fatty acid oxidation: carnitine deficiency, failing mitochondria and cardiomyopathy. Basic Res Cardiol. 1987. https:\/\/doi.org\/10.1007\/978-3-662-08390-1_8.","journal-title":"Basic Res Cardiol"},{"key":"8131_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2020.07.023","author":"SM Lam","year":"2020","unstructured":"Lam SM, et al. A robust, integrated platform for comprehensive analyses of acyl-coenzyme As and acyl-carnitines revealed chain length-dependent disparity in fatty acyl metabolic fates across Drosophila development. Sci Bull. 2020. https:\/\/doi.org\/10.1016\/j.scib.2020.07.023.","journal-title":"Sci Bull"},{"key":"8131_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094608","author":"N Zhang","year":"2022","unstructured":"Zhang N, et al. NMR Characterization of Long-Chain Fatty Acylcarnitine Binding to the Mitochondrial Carnitine\/Acylcarnitine Carrier. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23094608.","journal-title":"Int J Mol Sci"},{"key":"8131_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/aocs.12750","author":"J Zhou","year":"2023","unstructured":"Zhou J, et al. Physical, textural and crystallization characteristics of different chain length diacylglycerol-based solid fats. J Am Oil Chemists\u2019 Soc. 2023. https:\/\/doi.org\/10.1002\/aocs.12750.","journal-title":"J Am Oil Chemists\u2019 Soc"},{"key":"8131_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24183251","author":"M Almannai","year":"2019","unstructured":"Almannai M, Alfadhel M, El-Hattab AW. Carnitine Inborn Errors Metabolism Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24183251.","journal-title":"Carnitine Inborn Errors Metabolism Molecules"},{"key":"8131_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116565","author":"T Mazza","year":"2024","unstructured":"Mazza T, et al. Carnitine traffic and human fertility. Biochem Pharmacol. 2024. https:\/\/doi.org\/10.1016\/j.bcp.2024.116565.","journal-title":"Biochem Pharmacol"},{"key":"8131_CR37","unstructured":"Tanphaichitr V, Leelahagul P. Carnitine metabolism and human carnitine deficiency. Nutr. 1993;9(3):246\u201354."},{"key":"8131_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/104.6.782","author":"AC Tsai","year":"2023","unstructured":"Tsai AC, Romsos DR, Leveille GA. Significance of Dietary Carnitine for Growth and Carnitine Turnover in Rats. J Nutr. 2023. https:\/\/doi.org\/10.1093\/jn\/104.6.782.","journal-title":"J Nutr"},{"key":"8131_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-018-9448-1","author":"SJG Knottnerus","year":"2018","unstructured":"Knottnerus SJG, et al. Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle. Reviews Endocr Metabolic Disorders. 2018. https:\/\/doi.org\/10.1007\/s11154-018-9448-1.","journal-title":"Reviews Endocr Metabolic Disorders"},{"key":"8131_CR40","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.20-053","author":"W-S Chen","year":"2020","unstructured":"Chen W-S, et al. Decreases in Circulating Concentrations of Short-Chain Acylcarnitines are Associated with Systolic Function Improvement After Decompensated Heart Failure. Int Heart J. 2020. https:\/\/doi.org\/10.1536\/ihj.20-053.","journal-title":"Int Heart J"},{"key":"8131_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.1561","author":"A Davies","year":"2020","unstructured":"Davies A, et al. Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/ehjci\/ehaa946.1561.","journal-title":"Eur Heart J"},{"key":"8131_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131261","author":"A Davies","year":"2023","unstructured":"Davies A, et al. Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes. Int J Cardiol. 2023. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131261.","journal-title":"Int J Cardiol"},{"key":"8131_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.07.059","author":"F Kazak","year":"2017","unstructured":"Kazak F, Yarim GF. Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor. Neurosci Lett. 2017. https:\/\/doi.org\/10.1016\/j.neulet.2017.07.059.","journal-title":"Neurosci Lett"},{"key":"8131_CR44","doi-asserted-by":"publisher","unstructured":"Kido et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem. 2001;79(5):959\u201369. https:\/\/doi.org\/10.1046\/J.1471-4159.2001.00621.x.","DOI":"10.1046\/J.1471-4159.2001.00621.x"},{"key":"8131_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmd.2025.100072","author":"H Zhi","year":"2025","unstructured":"Zhi H, et al. Chronic liver injury decreases levels of cerebral carnitine and acetylcarnitine in rats partly due to the downregulation of organic cation transporters OCT1\/2 and OCTN2 at the blood-brain barrier. Drug Metab Dispos. 2025. https:\/\/doi.org\/10.1016\/j.dmd.2025.100072.","journal-title":"Drug Metab Dispos"},{"key":"8131_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.118.311373","author":"W-K Seo","year":"2018","unstructured":"Seo W-K, et al. Medium-Chain Acylcarnitines Are Associated With Cardioembolic Stroke and Stroke Recurrence. Thromb Vascular Biology. 2018. https:\/\/doi.org\/10.1161\/atvbaha.118.311373. Arteriosclerosis.","journal-title":"Thromb Vascular Biology"},{"key":"8131_CR47","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0000000000000248","author":"SI Hallan","year":"2023","unstructured":"Hallan SI, et al. Metabolic Differences in Diabetic Kidney Disease Patients with Normoalbuminuria versus Moderately Increased Albuminuria. Kidney360. 2023. https:\/\/doi.org\/10.34067\/kid.0000000000000248.","journal-title":"Kidney360"},{"key":"8131_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.12.003","author":"J-J Liu","year":"2017","unstructured":"Liu J-J, et al. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease. Kidney Int Rep. 2017. https:\/\/doi.org\/10.1016\/j.ekir.2016.12.003.","journal-title":"Kidney Int Rep"},{"key":"8131_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109070","author":"AN Gregor","year":"2025","unstructured":"Gregor AN, et al. D-BHB supplementation before moderate-intensity exercise suppresses lipolysis and selectively blunts exercise-induced long-chain acylcarnitine increase in pilot study of patients with long-chain fatty acid oxidation disorders. Mol Genet Metab. 2025. https:\/\/doi.org\/10.1016\/j.ymgme.2025.109070.","journal-title":"Mol Genet Metab"},{"key":"8131_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00870","author":"E Makarova","year":"2019","unstructured":"Makarova E, et al. Decreases in Circulating Concentrations of Long-Chain Acylcarnitines and Free Fatty Acids During the Glucose Tolerance Test Represent Tissue-Specific Insulin Sensitivity. Front Endocrinol. 2019. https:\/\/doi.org\/10.3389\/fendo.2019.00870.","journal-title":"Front Endocrinol"},{"key":"8131_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11040196","author":"M Tremblay-Gravel","year":"2021","unstructured":"Tremblay-Gravel M, et al. Long-Chain Acylcarnitines and Monounsaturated Fatty Acids Discriminate Heart Failure Patients According to Pulmonary Hypertension Status. Metabolites. 2021. https:\/\/doi.org\/10.3390\/metabo11040196.","journal-title":"Metabolites"},{"key":"8131_CR52","doi-asserted-by":"publisher","unstructured":"McCann MR, et al. L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine. Metabolites. 2021;11(1). https:\/\/doi.org\/10.3390\/metabo11010051.","DOI":"10.3390\/metabo11010051"},{"issue":"12","key":"8131_CR53","doi-asserted-by":"publisher","first-page":"102507","DOI":"10.1016\/j.xcrm.2025.102507","volume":"6","author":"R Lin","year":"2025","unstructured":"Lin R, et al. Targeting long-chain acylcarnitine accumulation to protect cardiac mitochondrial homeostasis after complete revascularization. Cell Rep Med. 2025;6(12):102507. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102507.","journal-title":"Cell Rep Med"},{"issue":"1","key":"8131_CR54","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41467-025-67513-x","volume":"17","author":"Z Lin","year":"2025","unstructured":"Lin Z, et al. Gut microbiota-derived metabolite isovalerylcarnitine modulates salt sensitivity of blood pressure and incident hypertension: a multicenter dietary salt intervention trial. Nat Commun. 2025;17(1):808. https:\/\/doi.org\/10.1038\/s41467-025-67513-x.","journal-title":"Nat Commun"},{"issue":"3","key":"8131_CR55","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","volume":"74","author":"M Dambrova","year":"2022","unstructured":"Dambrova M, et al. Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials. Pharmacol Rev. 2022;74(3):506\u201351. https:\/\/doi.org\/10.1124\/pharmrev.121.000408.","journal-title":"Pharmacol Rev"},{"key":"8131_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06341-5","author":"F Xiang","year":"2025","unstructured":"Xiang F, et al. Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation. J Translational Med. 2025. https:\/\/doi.org\/10.1186\/s12967-025-06341-5.","journal-title":"J Translational Med"},{"key":"8131_CR57","doi-asserted-by":"publisher","unstructured":"Panov AV, Mayorov VI, Dikalov SI. Role of fatty acids \u03b2-oxidation in the metabolic interactions between organs. Int J Mol Sci. 2024;25(23). https:\/\/doi.org\/10.3390\/ijms252312740.","DOI":"10.3390\/ijms252312740"},{"key":"8131_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/31.2.293","author":"ME Mitchell","year":"2023","unstructured":"Mitchell ME. Carnitine metabolism in human subjects I. Normal metabolism. Am J Clin Nutr. 2023. https:\/\/doi.org\/10.1093\/ajcn\/31.2.293.","journal-title":"Am J Clin Nutr"},{"key":"8131_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqaa140","author":"R Wedekind","year":"2020","unstructured":"Wedekind R, et al. A metabolomic study of red and processed meat intake and acylcarnitine concentrations in human urine and blood. Am J Clin Nutr. 2020. https:\/\/doi.org\/10.1093\/ajcn\/nqaa140.","journal-title":"Am J Clin Nutr"},{"key":"8131_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030525","author":"D Goldman","year":"2025","unstructured":"Goldman D, et al. Assessing the Roles of Retinol, Vitamin K2, Carnitine, and Creatine in Plant-Based Diets: A Narrative Review of Nutritional Adequacy and Health Implications. Nutrients. 2025. https:\/\/doi.org\/10.3390\/nu17030525.","journal-title":"Nutrients"},{"key":"8131_CR61","doi-asserted-by":"crossref","unstructured":"Idell-Wenger JA. Carnitine:acylcarnitine translocase of rat heart mitochondria: competition for carnitine uptake by carnitine esters. J Biol Chem. 1981;256(11):5597\u2013603.","DOI":"10.1016\/S0021-9258(19)69245-8"},{"key":"8131_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2018.11.007","author":"W Wang","year":"2018","unstructured":"Wang W, et al. Clozapine-induced reduction of l-carnitine reabsorption via inhibition\/down-regulation of renal carnitine\/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice. Toxicol Appl Pharmcol. 2018. https:\/\/doi.org\/10.1016\/j.taap.2018.11.007.","journal-title":"Toxicol Appl Pharmcol"},{"key":"8131_CR63","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.105.586107","author":"M Grube","year":"2006","unstructured":"Grube M, et al. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation. 2006. https:\/\/doi.org\/10.1161\/circulationaha.105.586107.","journal-title":"Circulation"},{"key":"8131_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.05.002","author":"E Liepinsh","year":"2014","unstructured":"Liepinsh E, et al. Selective inhibition of OCTN2 is more effective than inhibition of gamma-butyrobetaine dioxygenase to decrease the availability of l-carnitine and to reduce myocardial infarct size. Pharmacol Res. 2014. https:\/\/doi.org\/10.1016\/j.phrs.2014.05.002.","journal-title":"Pharmacol Res"},{"key":"8131_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2020.02.002","author":"G Wang","year":"2020","unstructured":"Wang G, et al. Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability. Asian J Pharm Sci. 2020. https:\/\/doi.org\/10.1016\/j.ajps.2020.02.002.","journal-title":"Asian J Pharm Sci"},{"issue":"Pt 3","key":"8131_CR66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/0264-6021:3610417","volume":"361","author":"FM Vaz","year":"2002","unstructured":"Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J. 2002;361(Pt 3):417\u201329. https:\/\/doi.org\/10.1042\/0264-6021:3610417.","journal-title":"Biochem J"},{"key":"8131_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/120.3.258","author":"Y-O Cho","year":"2023","unstructured":"Cho Y-O, Leklem JE. Vivo Evidence for a Vitamin B-6 Requirement in Carnitine Synthesis. J Nutr. 2023. https:\/\/doi.org\/10.1093\/jn\/120.3.258.","journal-title":"J Nutr"},{"key":"8131_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249451","author":"MN Maas","year":"2020","unstructured":"Maas MN, et al. Trimethyllysine: From Carnitine Biosynthesis to Epigenetics. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21249451.","journal-title":"Int J Mol Sci"},{"key":"8131_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/113.10.1906","author":"CJ Rebouche","year":"2023","unstructured":"Rebouche CJ. Effect of Dietary Carnitine Isomers and \u03b3-Butyrobetaine on L-Carnitine Biosynthesis and Metabolism in the Rat. J Nutr. 2023. https:\/\/doi.org\/10.1093\/jn\/113.10.1906.","journal-title":"J Nutr"},{"key":"8131_CR70","doi-asserted-by":"publisher","unstructured":"Tadiparthi K, Anand P. A journey toward the syntheses of \u03b3-amino-\u03b2-hydroxybutyric acid (GABOB) and carnitine. Org Process Res Dev. 2021. https:\/\/doi.org\/10.1021\/acs.oprd.1c00027.","DOI":"10.1021\/acs.oprd.1c00027"},{"key":"8131_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/104.12.1669","author":"V Tanphaichitr","year":"2023","unstructured":"Tanphaichitr V, Broquist HP. Site of Carnitine Biosynthesis in the Rat. J Nutr. 2023. https:\/\/doi.org\/10.1093\/jn\/104.12.1669.","journal-title":"J Nutr"},{"key":"8131_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s40337-025-01323-w","author":"M Lutter","year":"2025","unstructured":"Lutter M. Patients with anorexia nervosa have an increased burden of rare, damaging mutations in the BBOX1 gene. J Eat Disorders. 2025. https:\/\/doi.org\/10.1186\/s40337-025-01323-w.","journal-title":"J Eat Disorders"},{"key":"8131_CR73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2210247119","author":"ML Koleske","year":"2022","unstructured":"Koleske ML, et al. Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency. Proc Natl Acad Sci USA. 2022. https:\/\/doi.org\/10.1073\/pnas.2210247119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"8131_CR74","doi-asserted-by":"publisher","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","volume":"273","author":"I Tamai","year":"1998","unstructured":"Tamai I, et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem. 1998;273(32):20378\u201382. https:\/\/doi.org\/10.1074\/jbc.273.32.20378.","journal-title":"J Biol Chem"},{"key":"8131_CR75","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2018.1502273","author":"L Kou","year":"2018","unstructured":"Kou L, et al. Recent advances in drug delivery via the organic cation\/carnitine transporter 2 (OCTN2\/SLC22A5). Expert Opin Ther Targets. 2018. https:\/\/doi.org\/10.1080\/14728222.2018.1502273.","journal-title":"Expert Opin Ther Targets"},{"key":"8131_CR76","doi-asserted-by":"publisher","unstructured":"Ringseis R, Wen G, Eder K. Res PPAR. 2012;2012:868317. https:\/\/doi.org\/10.1155\/2012\/868317","DOI":"10.1155\/2012\/868317"},{"issue":"5","key":"8131_CR77","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1017\/s000711450775691x","volume":"98","author":"A Koch","year":"2007","unstructured":"Koch A, et al. Dietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats. Br J Nutr. 2007;98(5):882\u20139. https:\/\/doi.org\/10.1017\/s000711450775691x.","journal-title":"Br J Nutr"},{"issue":"9","key":"8131_CR78","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1124\/dmd.121.000702","volume":"50","author":"SW Yee","year":"2021","unstructured":"Yee SW, Giacomini KM. Emerging Roles of the Human Solute Carrier 22 Family. Drug Metab Dispos. 2021;50(9):1193\u2013210. https:\/\/doi.org\/10.1124\/dmd.121.000702.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"8131_CR79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ymgme.2007.08.002","volume":"92","author":"PS Shekhawat","year":"2007","unstructured":"Shekhawat PS, et al. Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-\/-)) mice. Mol Genet Metab. 2007;92(4):315\u201324. https:\/\/doi.org\/10.1016\/j.ymgme.2007.08.002.","journal-title":"Mol Genet Metab"},{"key":"8131_CR80","doi-asserted-by":"publisher","DOI":"10.1039\/d3mo00163f","author":"K Gong","year":"2023","unstructured":"Gong K, et al. Untargeted metabolomics analysis reveals spatial metabolic heterogeneity in different intestinal segments of type 1 diabetic mice. Mol Omics. 2023. https:\/\/doi.org\/10.1039\/d3mo00163f.","journal-title":"Mol Omics"},{"key":"8131_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.125491","author":"L Wang","year":"2023","unstructured":"Wang L, et al. On-tissue chemical derivatization-enhanced spatially resolved lipidomics reveals abnormal metabolism in type 2 diabetic rat brain. Talanta. 2023. https:\/\/doi.org\/10.1016\/j.talanta.2023.125491.","journal-title":"Talanta"},{"key":"8131_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.779683","author":"B Linnan","year":"2021","unstructured":"Linnan B, et al. In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease. Front Physiol. 2021. https:\/\/doi.org\/10.3389\/fphys.2021.779683.","journal-title":"Front Physiol"},{"key":"8131_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041191","author":"NV Khodorova","year":"2021","unstructured":"Khodorova NV, et al. Urinary Medium-Chained Acyl-Carnitines Sign High Caloric Intake whereas Short-Chained Acyl-Carnitines Sign High -Protein Diet within a High-Fat, Hypercaloric Diet in a Randomized Crossover Design Dietary Trial. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13041191.","journal-title":"Nutrients"},{"key":"8131_CR84","doi-asserted-by":"publisher","DOI":"10.1177\/00045632241239806","author":"Y Kobori","year":"2024","unstructured":"Kobori Y, et al. Low serum carnitine level is associated with increased urinary carnitine excretion in late pregnancy. Annals Clin Biochemistry: Int J Lab Med. 2024. https:\/\/doi.org\/10.1177\/00045632241239806.","journal-title":"Annals Clin Biochemistry: Int J Lab Med"},{"key":"8131_CR85","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy799","author":"Z Wang","year":"2018","unstructured":"Wang Z, et al. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J. 2018. https:\/\/doi.org\/10.1093\/eurheartj\/ehy799.","journal-title":"Eur Heart J"},{"key":"8131_CR86","doi-asserted-by":"publisher","DOI":"10.1161\/circ.118.suppl_18.s_538-a","author":"H Bugger","year":"2008","unstructured":"Bugger H, et al. Abstract 5379: Increased Myocardial Fatty Acid Uptake by Acyl-CoA Synthetase 1 Impairs Mitochondrial Function and Dynamics. Circulation. 2008. https:\/\/doi.org\/10.1161\/circ.118.suppl_18.s_538-a.","journal-title":"Circulation"},{"key":"8131_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155334","author":"H Dong","year":"2022","unstructured":"Dong H, et al. Loss of long-chain acyl-CoA synthetase 1 promotes hepatocyte death in alcohol-induced steatohepatitis. Metabolism. 2022. https:\/\/doi.org\/10.1016\/j.metabol.2022.155334.","journal-title":"Metabolism"},{"key":"8131_CR88","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.69802","author":"J Quan","year":"2022","unstructured":"Quan J, et al. Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGF\u03b21-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma. Int J Biol Sci. 2022. https:\/\/doi.org\/10.7150\/ijbs.69802.","journal-title":"Int J Biol Sci"},{"key":"8131_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101253","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. The fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase can be a source of mitochondrial hydrogen peroxide. Redox Biol. 2019. https:\/\/doi.org\/10.1016\/j.redox.2019.101253.","journal-title":"Redox Biol"},{"key":"8131_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.01.017","author":"K Wang","year":"2025","unstructured":"Wang K, et al. Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis. Acta Pharm Sinica B. 2025. https:\/\/doi.org\/10.1016\/j.apsb.2025.01.017.","journal-title":"Acta Pharm Sinica B"},{"key":"8131_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060817","author":"A Giudetti","year":"2016","unstructured":"Giudetti A, et al. Nutritional and Hormonal Regulation of Citrate and Carnitine\/Acylcarnitine Transporters: Two Mitochondrial Carriers Involved in Fatty Acid Metabolism. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17060817.","journal-title":"Int J Mol Sci"},{"key":"8131_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.07.004","author":"DA Nicholas","year":"2019","unstructured":"Nicholas DA, et al. Fatty Acid Metabolites Combine with Reduced \u03b2 Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes. Cell Metabol. 2019. https:\/\/doi.org\/10.1016\/j.cmet.2019.07.004.","journal-title":"Cell Metabol"},{"key":"8131_CR93","doi-asserted-by":"publisher","first-page":"779683","DOI":"10.3389\/fphys.2021.779683","volume":"12","author":"B Linnan","year":"2021","unstructured":"Linnan B, et al. In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease. Front Physiol. 2021;12:779683. https:\/\/doi.org\/10.3389\/fphys.2021.779683.","journal-title":"Front Physiol"},{"key":"8131_CR94","doi-asserted-by":"publisher","DOI":"10.1172\/jci165654","author":"S Mohandes","year":"2023","unstructured":"Mohandes S, et al. Molecular pathways that drive diabetic kidney disease. J Clin Investig. 2023. https:\/\/doi.org\/10.1172\/jci165654.","journal-title":"J Clin Investig"},{"key":"8131_CR95","unstructured":"!!! INVALID. CITATION !!! 75,95\u201397. doi."},{"issue":"3","key":"8131_CR96","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jdiacomp.2016.01.001","volume":"30","author":"AD Jagdale","year":"2016","unstructured":"Jagdale AD, et al. Strong inhibition of the polyol pathway diverts glucose flux to protein glycation leading to rapid establishment of secondary complications in diabetes mellitus. J Diabetes Complications. 2016;30(3):398\u2013405. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.01.001.","journal-title":"J Diabetes Complications"},{"key":"8131_CR97","doi-asserted-by":"publisher","first-page":"101799","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799. https:\/\/doi.org\/10.1016\/j.redox.2020.101799.","journal-title":"Redox Biol"},{"issue":"7441","key":"8131_CR98","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature11966","volume":"495","author":"V Chandra","year":"2013","unstructured":"Chandra V, et al. Multidomain integration in the structure of the HNF-4\u03b1 nuclear receptor complex. Nature. 2013;495(7441):394\u20138. https:\/\/doi.org\/10.1038\/nature11966.","journal-title":"Nature"},{"issue":"3","key":"8131_CR99","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cmet.2017.08.006","volume":"26","author":"J Simcox","year":"2017","unstructured":"Simcox J, et al. Global Analysis of Plasma Lipids Identifies Liver-Derived Acylcarnitines as a Fuel Source for Brown Fat Thermogenesis. Cell Metab. 2017;26(3):509\u2013e5226. https:\/\/doi.org\/10.1016\/j.cmet.2017.08.006.","journal-title":"Cell Metab"},{"key":"8131_CR100","doi-asserted-by":"publisher","unstructured":"Ito S, et al. Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease. JCI Insight. 2025;10(13). https:\/\/doi.org\/10.1172\/jci.insight.179362.","DOI":"10.1172\/jci.insight.179362"},{"issue":"10","key":"8131_CR101","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016;1863(10):2422\u201335. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.023.","journal-title":"Biochim Biophys Acta"},{"key":"8131_CR102","doi-asserted-by":"publisher","unstructured":"Wang N, Zhang C. Oxidative stress: a culprit in the progression of diabetic kidney disease. Antioxid (Basel). 2024;13(4). https:\/\/doi.org\/10.3390\/antiox13040455.","DOI":"10.3390\/antiox13040455"},{"issue":"4","key":"8131_CR103","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/15548627.2024.2435238","volume":"21","author":"L Pierre","year":"2025","unstructured":"Pierre L, et al. AMPK protects proximal tubular epithelial cells from lysosomal dysfunction and dedifferentiation induced by lipotoxicity. Autophagy. 2025;21(4):860\u201380. https:\/\/doi.org\/10.1080\/15548627.2024.2435238.","journal-title":"Autophagy"},{"issue":"9","key":"8131_CR104","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1158\/0008-5472.Can-09-3768","volume":"70","author":"C Marx","year":"2010","unstructured":"Marx C, et al. ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination. Cancer Res. 2010;70(9):3709\u201317. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-3768.","journal-title":"Cancer Res"},{"issue":"8","key":"8131_CR105","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.celrep.2015.04.048","volume":"11","author":"H Kim","year":"2015","unstructured":"Kim H, et al. Wnt Signaling Translocates Lys48-Linked Polyubiquitinated Proteins to the Lysosomal Pathway. Cell Rep. 2015;11(8):1151\u20139. https:\/\/doi.org\/10.1016\/j.celrep.2015.04.048.","journal-title":"Cell Rep"},{"key":"8131_CR106","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2016.05.003","volume":"116","author":"D Xu","year":"2017","unstructured":"Xu D, You G. Loops and layers of post-translational modifications of drug transporters. Adv Drug Deliv Rev. 2017;116:37\u201344. https:\/\/doi.org\/10.1016\/j.addr.2016.05.003.","journal-title":"Adv Drug Deliv Rev"},{"key":"8131_CR107","doi-asserted-by":"publisher","first-page":"108238","DOI":"10.1016\/j.pharmthera.2022.108238","volume":"237","author":"J Cai","year":"2022","unstructured":"Cai J, et al. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237:108238. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108238.","journal-title":"Pharmacol Ther"},{"key":"8131_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002456","author":"PY Chuang","year":"2007","unstructured":"Chuang PY, et al. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney Int. 2007. https:\/\/doi.org\/10.1038\/sj.ki.5002456.","journal-title":"Kidney Int"},{"key":"8131_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0523-3","author":"M Jaruskova","year":"2017","unstructured":"Jaruskova M, et al. Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment. J Experimental Clin Cancer Res. 2017. https:\/\/doi.org\/10.1186\/s13046-017-0523-3.","journal-title":"J Experimental Clin Cancer Res"},{"key":"8131_CR110","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.107.156877","author":"C-H Woo","year":"2008","unstructured":"Woo C-H, et al. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circul Res. 2008. https:\/\/doi.org\/10.1161\/circresaha.107.156877.","journal-title":"Circul Res"},{"key":"8131_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.12.019","author":"P Xu","year":"2022","unstructured":"Xu P, et al. Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis. Cell Metabol. 2022. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.019.","journal-title":"Cell Metabol"},{"key":"8131_CR112","doi-asserted-by":"publisher","unstructured":"Deragon MA, et al. Mitochondrial Trafficking of MLKL, Bak\/Bax, and Drp1 Is Mediated by RIP1 and ROS which Leads to Decreased Mitochondrial Membrane Integrity during the Hyperglycemic Shift to Necroptosis. Int J Mol Sci. 2023;24(10). https:\/\/doi.org\/10.3390\/ijms24108609.","DOI":"10.3390\/ijms24108609"},{"issue":"2","key":"8131_CR113","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0005-2736(01)00328-5","volume":"1512","author":"I Tamai","year":"2001","unstructured":"Tamai I, et al. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta. 2001;1512(2):273\u201384. https:\/\/doi.org\/10.1016\/s0005-2736(01)00328-5.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"8131_CR114","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1038\/s41598-020-62665-w","volume":"10","author":"S Aluksanasuwan","year":"2020","unstructured":"Aluksanasuwan S, et al. High glucose induces phosphorylation and oxidation of mitochondrial proteins in renal tubular cells: A proteomics approach. Sci Rep. 2020;10(1):5843. https:\/\/doi.org\/10.1038\/s41598-020-62665-w.","journal-title":"Sci Rep"},{"key":"8131_CR115","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.109.147504","author":"R Muniyappa","year":"2010","unstructured":"Muniyappa R. Oral Carnitine Therapy and Insulin Resistance. Hypertension. 2010. https:\/\/doi.org\/10.1161\/hypertensionaha.109.147504.","journal-title":"Hypertension"},{"key":"8131_CR116","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00063.2017","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018. https:\/\/doi.org\/10.1152\/physrev.00063.2017.","journal-title":"Physiol Rev"},{"key":"8131_CR117","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.153767","author":"P Ruggenenti","year":"2010","unstructured":"Ruggenenti P, van der Meer IM, Remuzzi G. Oral Acetyl-L-Carnitine Therapy and Insulin Resistance. Hypertension. 2010. https:\/\/doi.org\/10.1161\/hypertensionaha.110.153767.","journal-title":"Hypertension"},{"issue":"35","key":"8131_CR118","doi-asserted-by":"publisher","first-page":"18907","DOI":"10.1021\/acs.analchem.5c00828","volume":"97","author":"G Battaglia","year":"2025","unstructured":"Battaglia G, et al. Assessing Acetyl-Coenzyme A Carboxylase Activity and Inhibition in Caenorhabtidis elegans Using a Partially Purified Protein Extract. Anal Chem. 2025;97(35):18907\u201317. https:\/\/doi.org\/10.1021\/acs.analchem.5c00828.","journal-title":"Anal Chem"},{"issue":"3","key":"8131_CR119","doi-asserted-by":"publisher","first-page":"100051","DOI":"10.1016\/j.pharmr.2025.100051","volume":"77","author":"R Rodr\u00edguez-Rodr\u00edguez","year":"2025","unstructured":"Rodr\u00edguez-Rodr\u00edguez R, et al. International Union of Basic and Clinical Pharmacology. CXIX. Fundamental insights and clinical relevance regarding the carnitine palmitoyltransferase family of enzymes. Pharmacol Rev. 2025;77(3):100051. https:\/\/doi.org\/10.1016\/j.pharmr.2025.100051.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"8131_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","volume":"62","author":"MG Schooneman","year":"2013","unstructured":"Schooneman MG, et al. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes. 2013;62(1):1\u20138. https:\/\/doi.org\/10.2337\/db12-0466.","journal-title":"Diabetes"},{"key":"8131_CR121","unstructured":"Vo\u013cska K. Protective effects and mechanisms of action of methyl-GBB in the preclinical models of diabetes and its complications. 2019. doi:"},{"key":"8131_CR122","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0223","author":"J-H Hong","year":"2021","unstructured":"Hong J-H, Lee M-K. Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway. Diabetes Metabolism J. 2021. https:\/\/doi.org\/10.4093\/dmj.2020.0223.","journal-title":"Diabetes Metabolism J"},{"key":"8131_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.11.014","author":"E Liepinsh","year":"2015","unstructured":"Liepinsh E, et al. Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance. Pharmacol Res. 2015. https:\/\/doi.org\/10.1016\/j.phrs.2015.11.014.","journal-title":"Pharmacol Res"},{"issue":"11","key":"8131_CR124","doi-asserted-by":"publisher","first-page":"101187","DOI":"10.1016\/j.jhepr.2024.101187","volume":"6","author":"IW Zhang","year":"2024","unstructured":"Zhang IW, et al. Palmitoylcarnitine impairs immunity in decompensated cirrhosis. JHEP Rep. 2024;6(11):101187. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101187.","journal-title":"JHEP Rep"},{"issue":"1","key":"8131_CR125","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41420-025-02771-8","volume":"11","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, et al. Targeting GPX2 to disrupt lipid homeostasis and enhance cisplatin sensitivity in diffuse gastric cancer. Cell Death Discov. 2025;11(1):491. https:\/\/doi.org\/10.1038\/s41420-025-02771-8.","journal-title":"Cell Death Discov"},{"issue":"Pt 1","key":"8131_CR126","doi-asserted-by":"publisher","first-page":"149021","DOI":"10.1016\/j.ijbiomac.2025.149021","volume":"334","author":"S Jiang","year":"2025","unstructured":"Jiang S, et al. Lipocalin 2 deficiency attenuates NLRP3 inflammasome activation through glycolysis impairment and MGST1-mediated mitochondrial ROS reduction. Int J Biol Macromol. 2025;334(Pt 1):149021. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149021.","journal-title":"Int J Biol Macromol"},{"key":"8131_CR127","doi-asserted-by":"publisher","DOI":"10.1134\/s1990747823050045","author":"NI Fedotcheva","year":"2023","unstructured":"Fedotcheva NI, Grishina EV, Dynnik VV. Involvement of the Mitochondrial Ca2+-Independent Phospholipase iPLA2 in the Induction of Mitochondrial Permeability Transition Pore by Long-Chain Acylcarnitines. Biochemistry (Moscow). Supplement Ser A: Membrane Cell Biology. 2023. https:\/\/doi.org\/10.1134\/s1990747823050045.","journal-title":"Supplement Ser A: Membrane Cell Biology"},{"key":"8131_CR128","doi-asserted-by":"publisher","DOI":"10.1042\/bcj20160164","author":"E Liepinsh","year":"2016","unstructured":"Liepinsh E, et al. Long-chain acylcarnitines determine ischaemia\/reperfusion-induced damage in heart mitochondria. Biochem J. 2016. https:\/\/doi.org\/10.1042\/bcj20160164.","journal-title":"Biochem J"},{"key":"8131_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.616834","author":"AO Verkerk","year":"2020","unstructured":"Verkerk AO, et al. Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.616834.","journal-title":"Front Pharmacol"},{"key":"8131_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2017.02.011","author":"AJ Blanca","year":"2017","unstructured":"Blanca AJ, et al. l-Carnitine ameliorates the oxidative stress response to angiotensin II by modulating NADPH oxidase through a reduction in protein kinase c activity and NF-\u03baB translocation to the nucleus. Food Chem. 2017. https:\/\/doi.org\/10.1016\/j.foodchem.2017.02.011.","journal-title":"Food Chem"},{"key":"8131_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-19-32","author":"J-L Li","year":"2012","unstructured":"Li J-L, et al. Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha. J Biomed Sci. 2012. https:\/\/doi.org\/10.1186\/1423-0127-19-32.","journal-title":"J Biomed Sci"},{"key":"8131_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2006.04.003","author":"H Mansour","year":"2006","unstructured":"Mansour H. Protective role of carnitine ester against radiation-induced oxidative stress in rats. Pharmacol Res. 2006. https:\/\/doi.org\/10.1016\/j.phrs.2006.04.003.","journal-title":"Pharmacol Res"},{"key":"8131_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2015.11.007","author":"DS Salmanoglu","year":"2016","unstructured":"Salmanoglu DS, et al. Melatonin and L-carnitin improves endothelial disfunction and oxidative stress in Type 2 diabetic rats. Redox Biol. 2016. https:\/\/doi.org\/10.1016\/j.redox.2015.11.007.","journal-title":"Redox Biol"},{"key":"8131_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.860588","author":"X-Y Yu","year":"2022","unstructured":"Yu X-Y, et al. TGF-\u03b2\/Smad Signaling Pathway in Tubulointerstitial Fibrosis. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.860588.","journal-title":"Front Pharmacol"},{"issue":"1","key":"8131_CR135","doi-asserted-by":"publisher","first-page":"e87205","DOI":"10.1371\/journal.pone.0087205","volume":"9","author":"PH Lou","year":"2014","unstructured":"Lou PH, et al. The mechanism of Intralipid\u00ae-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases. PLoS ONE. 2014;9(1):e87205. https:\/\/doi.org\/10.1371\/journal.pone.0087205.","journal-title":"PLoS ONE"},{"key":"8131_CR136","doi-asserted-by":"publisher","unstructured":"Aranda-Rivera AK, et al. Mitochondrial redox signaling and oxidative stress in kidney diseases. Biomolecules. 2021;11(8). https:\/\/doi.org\/10.3390\/biom11081144.","DOI":"10.3390\/biom11081144"},{"key":"8131_CR137","doi-asserted-by":"publisher","unstructured":"G\u00fcnthel M, et al. Epigenetic state changes underlie metabolic switch in mouse post-infarction border zone cardiomyocytes. J Cardiovasc Dev Dis. 2021;8(11). https:\/\/doi.org\/10.3390\/jcdd8110134.","DOI":"10.3390\/jcdd8110134"},{"key":"8131_CR138","doi-asserted-by":"publisher","first-page":"110838","DOI":"10.1016\/j.cellsig.2023.110838","volume":"110","author":"K Zeng","year":"2023","unstructured":"Zeng K, et al. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS\/PPAR\u03b3\/NF-\u03baB pathway in clear cell renal cell carcinoma. Cell Signal. 2023;110:110838. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110838.","journal-title":"Cell Signal"},{"key":"8131_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00462-y","author":"M Oshima","year":"2021","unstructured":"Oshima M, et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021. https:\/\/doi.org\/10.1038\/s41581-021-00462-y.","journal-title":"Nat Rev Nephrol"},{"key":"8131_CR140","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.13638","author":"S Daimon","year":"2021","unstructured":"Daimon S, Yasuda M, Nishitani M. Serum carnitine concentration and the acyl to free carnitine ratio in nondialysis chronic kidney disease and hemodialysis patients. Therapeutic Apheresis Dialysis. 2021. https:\/\/doi.org\/10.1111\/1744-9987.13638.","journal-title":"Therapeutic Apheresis Dialysis"},{"key":"8131_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1155281","author":"W Ito","year":"2023","unstructured":"Ito W, et al. Correlation between acylcarnitine\/free carnitine ratio and cardiopulmonary exercise test parameters in patients with incident dialysis. Front Physiol. 2023. https:\/\/doi.org\/10.3389\/fphys.2023.1155281.","journal-title":"Front Physiol"},{"key":"8131_CR142","doi-asserted-by":"publisher","DOI":"10.1134\/s1990747822010068","author":"NI Fedotcheva","year":"2022","unstructured":"Fedotcheva NI, Grishina EV, Dynnik VV. Induction of Mitochondrial Cyclosporin-Dependent Permeability Transition Pore by Acylcarnitines. Effects of Concentrations and Carbon Chain Length. Biochemistry (Moscow). Supplement Ser A: Membrane Cell Biology. 2022. https:\/\/doi.org\/10.1134\/s1990747822010068.","journal-title":"Supplement Ser A: Membrane Cell Biology"},{"key":"8131_CR143","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2022.2063430","author":"H-X Liu","year":"2022","unstructured":"Liu H-X, Liu Q-J. Logistic role of carnitine shuttle system on radiation-induced L-carnitine and acylcarnitines alteration. Int J Radiat Biol. 2022. https:\/\/doi.org\/10.1080\/09553002.2022.2063430.","journal-title":"Int J Radiat Biol"},{"key":"8131_CR144","doi-asserted-by":"publisher","DOI":"10.1161\/res.125.suppl_1.452","author":"JB Lerman","year":"2019","unstructured":"Lerman JB, et al. Abstract 452: A Unique Acylcarnitine Profile is Independently Associated with Diabetic Heart Failure and Associates with Adverse Clinical Outcomes: Insights from the FIGHT Trial. Circul Res. 2019. https:\/\/doi.org\/10.1161\/res.125.suppl_1.452.","journal-title":"Circul Res"},{"key":"8131_CR145","doi-asserted-by":"publisher","DOI":"10.2337\/db25-1414-p","author":"C Menzaghi","year":"2025","unstructured":"Menzaghi C, et al. 1414-P: Role of Circulating Acylcarnitines on Renal Function Decline in Patients with Type 2 Diabetes. Diabetes. 2025. https:\/\/doi.org\/10.2337\/db25-1414-p.","journal-title":"Diabetes"},{"key":"8131_CR146","doi-asserted-by":"publisher","DOI":"10.1161\/circ.142.suppl_3.15589","author":"JA Regan","year":"2020","unstructured":"Regan JA, et al. Abstract 15589: Mitochondrial Metabolites Predict Cardiovascular Outcomes and Heart Failure in People With Type 2 Diabetes Mellitus and Vascular Disease: A Tecos Substudy. Circulation. 2020. https:\/\/doi.org\/10.1161\/circ.142.suppl_3.15589.","journal-title":"Circulation"},{"key":"8131_CR147","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5952","author":"S Bora","year":"2024","unstructured":"Bora S, et al. GC\u2013MS validation and analysis of targeted plasma metabolites related to carbonyl stress in type 2 diabetes mellitus patients with and without acute coronary syndrome. Biomed Chromatogr. 2024. https:\/\/doi.org\/10.1002\/bmc.5952.","journal-title":"Biomed Chromatogr"},{"key":"8131_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1584049","author":"H Mu","year":"2025","unstructured":"Mu H, et al. The serum uric acid to creatinine ratio as a diagnostic biomarker for normoalbuminuric diabetic kidney disease. Front Med. 2025. https:\/\/doi.org\/10.3389\/fmed.2025.1584049.","journal-title":"Front Med"},{"key":"8131_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.834205","author":"W-Y Wang","year":"2022","unstructured":"Wang W-Y, et al. Relationship Between Acylcarnitine and the Risk of Retinopathy in Type 2 Diabetes Mellitus. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.834205.","journal-title":"Front Endocrinol"},{"key":"8131_CR150","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7079","author":"D Zhang","year":"2019","unstructured":"Zhang D, Ye S, Pan T. The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes. PeerJ. 2019. https:\/\/doi.org\/10.7717\/peerj.7079.","journal-title":"PeerJ"},{"key":"8131_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.11.122","author":"AT Ahmed","year":"2019","unstructured":"Ahmed AT, et al. Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes. J Affect Disord. 2019. https:\/\/doi.org\/10.1016\/j.jad.2019.11.122.","journal-title":"J Affect Disord"},{"key":"8131_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.03.001","author":"K Abe","year":"2017","unstructured":"Abe K, et al. Matrix effect\u2013corrected liquid chromatography\/tandem mass-spectrometric method for determining acylcarnitines in human urine. Clin Chim Acta. 2017. https:\/\/doi.org\/10.1016\/j.cca.2017.03.001.","journal-title":"Clin Chim Acta"},{"key":"8131_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.04.026","author":"K Mirzoyan","year":"2017","unstructured":"Mirzoyan K, et al. Increased urine acylcarnitines in diabetic ApoE-\/- mice: Hydroxytetradecadienoylcarnitine (C14:2-OH) reflects diabetic nephropathy in a context of hyperlipidemia. Biochem Biophys Res Commun. 2017. https:\/\/doi.org\/10.1016\/j.bbrc.2017.04.026.","journal-title":"Biochem Biophys Res Commun"},{"key":"8131_CR154","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-024-02161-8","author":"C Pretorius","year":"2024","unstructured":"Pretorius C, Luies L. Characterising the urinary acylcarnitine and amino acid profiles of HIV\/TB co-infection, using LC\u2013MS metabolomics. Metabolomics. 2024. https:\/\/doi.org\/10.1007\/s11306-024-02161-8.","journal-title":"Metabolomics"},{"key":"8131_CR155","doi-asserted-by":"publisher","unstructured":"Mogos M, et al. Biomarker profiling with targeted metabolomic analysis of plasma and urine samples in patients with type 2 Diabetes mellitus and early diabetic kidney disease. J Clin Med. 2024;13(16). https:\/\/doi.org\/10.3390\/jcm13164703.","DOI":"10.3390\/jcm13164703"},{"issue":"1","key":"8131_CR156","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jmd2.12334","volume":"64","author":"LL Crefcoeur","year":"2023","unstructured":"Crefcoeur LL, et al. Assessment of carnitine excretion and its ratio to plasma free carnitine as a biomarker for primary carnitine deficiency in newborns. JIMD Rep. 2023;64(1):57\u201364. https:\/\/doi.org\/10.1002\/jmd2.12334.","journal-title":"JIMD Rep"},{"key":"8131_CR157","doi-asserted-by":"publisher","unstructured":"Rinaldi A, et al. Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury. JCI Insight. 2022;7(18). https:\/\/doi.org\/10.1172\/jci.insight.161783.","DOI":"10.1172\/jci.insight.161783"},{"issue":"8","key":"8131_CR158","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1016\/j.ekir.2025.05.034","volume":"10","author":"B Requena","year":"2025","unstructured":"Requena B, et al. Lipidomics Unveils Critical Lipid Pathway Shifts in Alport Syndrome. Kidney Int Rep. 2025;10(8):2805\u201320. https:\/\/doi.org\/10.1016\/j.ekir.2025.05.034.","journal-title":"Kidney Int Rep"},{"key":"8131_CR159","doi-asserted-by":"publisher","DOI":"10.2337\/db19-2422-pub","author":"M Razo-Azamar","year":"2019","unstructured":"Razo-Azamar M, et al. 2422-PUB: Short-Chain Acylcarnitines as Early Predictors of Gestational Diabetes in Mexican Population. Diabetes. 2019. https:\/\/doi.org\/10.2337\/db19-2422-pub.","journal-title":"Diabetes"},{"key":"8131_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1099-0844(199809)16:3<165::aid-cbf782>3.0.co;2-2","author":"AS Alhomida","year":"1998","unstructured":"Alhomida AS. Investigation of the effect of theophylline administration on total, free, short-chain acyl and long-chain acyl carnitine distributions in rat renal tissues. Cell Biochem Funct. 1998. https:\/\/doi.org\/10.1002\/(sici)1099-0844(199809)16:3%26lt;165::aid-cbf782%26gt;3.0.co;2-2.","journal-title":"Cell Biochem Funct"},{"key":"8131_CR161","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/115.10.1267","author":"SD Brooks","year":"2023","unstructured":"Brooks SD, Bahl JJ, Bressler R. Carnitine in the Streptozotocin-Diabetic Rat. J Nutr. 2023. https:\/\/doi.org\/10.1093\/jn\/115.10.1267.","journal-title":"J Nutr"},{"key":"8131_CR162","doi-asserted-by":"publisher","unstructured":"Yoshino et al. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect. J Chromatogr B, 2003;792(1):73\u201382. https:\/\/doi.org\/10.1016\/s1570-0232(03)00310-6.","DOI":"10.1016\/s1570-0232(03)00310-6"},{"key":"8131_CR163","doi-asserted-by":"publisher","DOI":"10.2337\/db20-531-p","author":"AE Rumora","year":"2020","unstructured":"Rumora AE, et al. 531-P: Metabolomics Identifies Novel Plasma Metabolomic Signatures Associated with Diabetic Neuropathy in a Cohort with Screen-Tested Type 2 Diabetes: ADDITION-Denmark. Diabetes. 2020. https:\/\/doi.org\/10.2337\/db20-531-p.","journal-title":"Diabetes"},{"key":"8131_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(88)90106-0","author":"C Wanner","year":"1988","unstructured":"Wanner C, Schollmeyer P, H\u00f6rl WH. Serum carnitine levels and carnitine esters of patients after kidney transplantation: role of immunosuppression. Metabolism. 1988. https:\/\/doi.org\/10.1016\/0026-0495(88)90106-0.","journal-title":"Metabolism"},{"key":"8131_CR165","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5747","author":"MH Hassan","year":"2023","unstructured":"Hassan MH, et al. Profile of plasma free amino acids, carnitine and acylcarnitines, and JAK2v617f mutation as potential metabolic markers in children with type 1 diabetic nephropathy. Biomed Chromatogr. 2023. https:\/\/doi.org\/10.1002\/bmc.5747.","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"8131_CR166","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13098-023-01058-1","volume":"15","author":"X Li","year":"2023","unstructured":"Li X, et al. The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2023;15(1):130. https:\/\/doi.org\/10.1186\/s13098-023-01058-1.","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"8131_CR167","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/imna-d-24-00045","volume":"12","author":"M Li","year":"2025","unstructured":"Li M, Chen X, Li Q. Advances in the Treatment of Refractory Membranous Nephropathy with Integrative Medicine. Integr Med Nephrol Androl. 2025;12(3):e24\u201300045. https:\/\/doi.org\/10.1097\/imna-d-24-00045.","journal-title":"Integr Med Nephrol Androl"},{"issue":"2","key":"8131_CR168","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/mnh.0000000000000584","volume":"29","author":"J Nespoux","year":"2020","unstructured":"Nespoux J, Vallon V. Renal effects of SGLT2 inhibitors: an update. Curr Opin Nephrol Hypertens. 2020;29(2):190\u20138. https:\/\/doi.org\/10.1097\/mnh.0000000000000584.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"8131_CR169","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/imna-d-24-00064","volume":"12","author":"H Wang","year":"2025","unstructured":"Wang H, et al. The Clinical Effectiveness of Anti-TGF-\u03b2 Therapy in Chronic Kidney Disease: A Systematic Review of Western and Traditional Chinese Medicine. Integr Med Nephrol Androl. 2025;12(3):e24\u201300064. https:\/\/doi.org\/10.1097\/imna-d-24-00064.","journal-title":"Integr Med Nephrol Androl"},{"key":"8131_CR170","doi-asserted-by":"publisher","unstructured":"Trischitta V, et al. Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2023;11(5). https:\/\/doi.org\/10.1136\/bmjdrc-2023-003422.","DOI":"10.1136\/bmjdrc-2023-003422"},{"issue":"2","key":"8131_CR171","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.01.014","volume":"60","author":"ON Goek","year":"2012","unstructured":"Goek ON, et al. Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis. 2012;60(2):197\u2013206. https:\/\/doi.org\/10.1053\/j.ajkd.2012.01.014.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"8131_CR172","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12933-025-02643-6","volume":"24","author":"T Agur","year":"2025","unstructured":"Agur T, et al. The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study. Cardiovasc Diabetol. 2025;24(1):97. https:\/\/doi.org\/10.1186\/s12933-025-02643-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"8131_CR173","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41440-020-00590-1","volume":"44","author":"K Kitamura","year":"2021","unstructured":"Kitamura K, et al. Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients-the role of antidiabetic and antihypertensive medications. Hypertens Res. 2021;44(5):508\u201317. https:\/\/doi.org\/10.1038\/s41440-020-00590-1.","journal-title":"Hypertens Res"},{"key":"8131_CR174","doi-asserted-by":"publisher","unstructured":"Gianazza E, et al. Pharmacometabolomics for the study of lipid-lowering therapies: opportunities and challenges. Int J Mol Sci. 2023;24(4). https:\/\/doi.org\/10.3390\/ijms24043291.","DOI":"10.3390\/ijms24043291"},{"issue":"5","key":"8131_CR175","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/ajcn\/nqy356","volume":"109","author":"SM Ulven","year":"2019","unstructured":"Ulven SM, et al. Using metabolic profiling and gene expression analyses to explore molecular effects of replacing saturated fat with polyunsaturated fat-a randomized controlled dietary intervention study. Am J Clin Nutr. 2019;109(5):1239\u201350. https:\/\/doi.org\/10.1093\/ajcn\/nqy356.","journal-title":"Am J Clin Nutr"},{"issue":"1\u20132","key":"8131_CR176","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ymgme.2020.09.001","volume":"131","author":"G Elizondo","year":"2020","unstructured":"Elizondo G, et al. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD\/TFPD. Mol Genet Metab. 2020;131(1\u20132):90\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2020.09.001.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"8131_CR177","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.1038\/s41467-025-66046-7","volume":"16","author":"R Pope","year":"2025","unstructured":"Pope R, et al. Faecal metabolites as a readout of habitual diet capture dietary interactions with the gut microbiome. Nat Commun. 2025;16(1):10051. https:\/\/doi.org\/10.1038\/s41467-025-66046-7.","journal-title":"Nat Commun"},{"issue":"1","key":"8131_CR178","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcmgh.2023.09.005","volume":"17","author":"JMS Lemons","year":"2024","unstructured":"Lemons JMS, et al. Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2024;17(1):131\u201348. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.09.005.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"8131_CR179","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.aca.2018.07.068","volume":"1032","author":"J Hertel","year":"2018","unstructured":"Hertel J, et al. Dilution correction for dynamically influenced urinary analyte data. Anal Chim Acta. 2018;1032:18\u201331. https:\/\/doi.org\/10.1016\/j.aca.2018.07.068.","journal-title":"Anal Chim Acta"},{"issue":"19","key":"8131_CR180","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1007\/s00216-025-05943-8","volume":"417","author":"B Gukalova","year":"2025","unstructured":"Gukalova B, et al. LC-MS\/MS-based simultaneous quantification of acylcarnitines, eicosapentaenoic acid, and docosahexaenoic acid: exploring potential biomarkers in human plasma. Anal Bioanal Chem. 2025;417(19):4299\u2013309. https:\/\/doi.org\/10.1007\/s00216-025-05943-8.","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"8131_CR181","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2215\/cjn.07650717","volume":"13","author":"F Wang","year":"2018","unstructured":"Wang F, et al. Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate. Clin J Am Soc Nephrol. 2018;13(4):560\u20138. https:\/\/doi.org\/10.2215\/cjn.07650717.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"8131_CR182","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41598-025-86081-0","volume":"15","author":"L Tan","year":"2025","unstructured":"Tan L, et al. Clinical features, pathological characteristics, and prognosis of patients with IgA nephropathy complicated with nephrotic syndrome. Sci Rep. 2025;15(1):1804. https:\/\/doi.org\/10.1038\/s41598-025-86081-0.","journal-title":"Sci Rep"},{"key":"8131_CR183","doi-asserted-by":"publisher","unstructured":"Rotter M, et al. Night Shift Work Affects Urine Metabolite Profiles of Nurses with Early Chronotype. Metabolites. 2018;8(3). https:\/\/doi.org\/10.3390\/metabo8030045.","DOI":"10.3390\/metabo8030045"},{"issue":"3","key":"8131_CR184","doi-asserted-by":"publisher","first-page":"E494","DOI":"10.9778\/cmajo.20220039","volume":"11","author":"AF Ozaki","year":"2023","unstructured":"Ozaki AF, et al. Prescribing patterns and factors associated with sodium-glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease. CMAJ Open. 2023;11(3):E494\u2013503. https:\/\/doi.org\/10.9778\/cmajo.20220039.","journal-title":"CMAJ Open"},{"key":"8131_CR185","unstructured":"Ltd. S.-A.S.S.P. A Randomized, Open-label, 2-Way-Crossover Study Assessing the Bioequivalence between Single Doses of 500\u00a0mg Glucophage Immediate Release (GIR) Tablets (Sino-American Shanghai Squibb Pharmaceuticals Ltd.\/ Manufactured in China) and 500\u00a0mg GIR Tablets (Merck Sant\u00e9 s.a.s. in Semoy\/ Manufactured in France) under Fed and Fasted State in Two Groups of Healthy Subjects. 2017; Available from: https:\/\/cdn.clinicaltrials.gov\/large-docs\/08\/NCT03393208\/Prot_000.pdf"},{"issue":"2","key":"8131_CR186","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41436-020-00990-1","volume":"23","author":"MJ Miller","year":"2021","unstructured":"Miller MJ, et al. Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(2):249\u201358. https:\/\/doi.org\/10.1038\/s41436-020-00990-1.","journal-title":"Genet Med"},{"issue":"1","key":"8131_CR187","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1038\/s41467-022-33050-0","volume":"13","author":"KF Dekkers","year":"2022","unstructured":"Dekkers KF, et al. An online atlas of human plasma metabolite signatures of gut microbiome composition. Nat Commun. 2022;13(1):5370. https:\/\/doi.org\/10.1038\/s41467-022-33050-0.","journal-title":"Nat Commun"},{"issue":"11","key":"8131_CR188","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.stemcr.2023.09.002","volume":"18","author":"M Loos","year":"2023","unstructured":"Loos M, et al. Human model of primary carnitine deficiency cardiomyopathy reveals ferroptosis as a novel mechanism. Stem Cell Rep. 2023;18(11):2123\u201337. https:\/\/doi.org\/10.1016\/j.stemcr.2023.09.002.","journal-title":"Stem Cell Rep"},{"key":"8131_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.010","volume":"135","author":"ML Rives","year":"2017","unstructured":"Rives ML, Javitch JA, Wickenden AD. Potentiating SLC transporter activity: Emerging drug discovery opportunities. Biochem Pharmacol. 2017;135:1\u201311. https:\/\/doi.org\/10.1016\/j.bcp.2017.02.010.","journal-title":"Biochem Pharmacol"},{"key":"8131_CR190","doi-asserted-by":"publisher","unstructured":"Blagonravov M, et al. Gene therapy for heart failure: impact on mitochondrial dysfunction. Biomedicines. 2026;14(2). https:\/\/doi.org\/10.3390\/biomedicines14020344.","DOI":"10.3390\/biomedicines14020344"},{"issue":"3","key":"8131_CR191","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.stemcr.2015.07.002","volume":"5","author":"M Vunjak-Novakovic","year":"2015","unstructured":"Vunjak-Novakovic M. Modeling primary carnitine deficiency-mediated dilated cardiomyopathy in engineered heart tissue format. Stem Cell Rep. 2015;5(3):489\u2013501. https:\/\/doi.org\/10.1016\/j.stemcr.2015.07.002.","journal-title":"Stem Cell Rep"},{"issue":"3","key":"8131_CR192","doi-asserted-by":"publisher","first-page":"e70043","DOI":"10.1002\/jimd.70043","volume":"48","author":"A Ramosaj","year":"2025","unstructured":"Ramosaj A, et al. Novel Treatment Strategy for Patients With Urea Cycle Disorders: Pharmacological Chaperones Enhance Enzyme Stability and Activity in Patient-Derived Liver Disease Models. J Inherit Metab Dis. 2025;48(3):e70043. https:\/\/doi.org\/10.1002\/jimd.70043.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"8131_CR193","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1080\/14756366.2021.1975694","volume":"36","author":"R Iacono","year":"2021","unstructured":"Iacono R, et al. Carnitine is a pharmacological allosteric chaperone of the human lysosomal \u03b1-glucosidase. J Enzyme Inhib Med Chem. 2021;36(1):2068\u201379. https:\/\/doi.org\/10.1080\/14756366.2021.1975694.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"5","key":"8131_CR194","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1111\/dom.16298","volume":"27","author":"YMH Op den Kamp-Bruls","year":"2025","unstructured":"Op den Kamp-Bruls YMH, et al. Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes. Diabetes Obes Metab. 2025;27(5):2864\u201377. https:\/\/doi.org\/10.1111\/dom.16298.","journal-title":"Diabetes Obes Metab"},{"key":"8131_CR195","unstructured":"Miller K, Taylor GR. Efficacy and safety of drug Z in patients with chronic kidney disease stage 3\u20134. 2025 Oct 12."},{"key":"8131_CR196","unstructured":"Smith A, Wilson DB. A randomized controlled trial of agent Y for reducing albuminuria in type 2 diabetic patients. 2009."},{"key":"8131_CR197","unstructured":"Johnson L, Clark BK. A phase 3 trial of drug X for the treatment of diabetic nephropathy with microalbuminuria. 2012."},{"key":"8131_CR198","unstructured":"Mueller S, Koch BT. A multicenter study of therapy Y for moderate chronic kidney disease. 2006."},{"key":"8131_CR199","unstructured":"J S. L. K, and W. H. A phase 3 study of drug X in patients with type 2 diabetes mellitus. 2014."},{"key":"8131_CR200","doi-asserted-by":"crossref","unstructured":"Jones A, Brown MB. A randomized trial of drug X for chronic kidney disease. 2009 Mar 15.","DOI":"10.1053\/j.ackd.2007.10.008"},{"key":"8131_CR201","unstructured":"Zhang L, Chen WH. A phase 2 study of novel therapy Y for diabetic nephropathy. 2024 Jan 10."},{"key":"8131_CR202","unstructured":"Chen M, Zhao LJ. A multicenter trial of therapy X for patients with early diabetic nephropathy. 2023."},{"key":"8131_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.06.002","author":"C Jang","year":"2019","unstructured":"Jang C, et al. Metabolite Exchange between Mammalian Organs Quantified in Pigs. Cell Metabol. 2019. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.002","journal-title":"Cell Metabol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08131-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:28:33Z","timestamp":1781742513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08131-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":203,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8131"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08131-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"781"}}